FGF2 and neoplasm: The dodecasaccharide reduced the number of phospho-FRS2-positive blood vessels by 47% (Fig 5E and 5F), showing that [NSIS6S]-[NSIS]5 is an effective inhibitor of FGF2-mediated tumor angiogenesis.